Integrity Alliance’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$734K Buy
19,983
+1,053
+6% +$49.9K 0.03% 359
2025
Q4
$963K Buy
18,930
+9,907
+110% +$507K 0.04% 320
2025
Q3
$501K Sell
9,023
-9,033
-50% -$529K 0.02% 353
2025
Q2
$1.25M Sell
18,056
-3,860
-18% -$263K 0.07% 195
2025
Q1
$1.52M Buy
+21,916
New +$1.81M 0.06% 218

Other funds holding NVO

Integrity Alliance's NVO Position: Q1 2026 in Review

Integrity Alliance increased its Novo Nordisk (NVO) stake by 5.6% in Q1 2026, buying an estimated $49.9K and bringing the position to 19,983 shares worth $734K. The position accounts for 0.03% of the portfolio, ranked #359.

Integrity Alliance first reported a position in NVO in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.52M in Q1 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Integrity Alliance held 19,983 shares of Novo Nordisk worth $734K as of Q1 2026.
  • Integrity Alliance bought 1,053 Novo Nordisk shares in Q1 2026, an estimated $49.9K.
  • Novo Nordisk made up 0.03% of Integrity Alliance's portfolio in Q1 2026, its #359 holding.
  • Integrity Alliance first reported a position in Novo Nordisk in Q1 2025 and has held it in 5 quarters since.
  • Integrity Alliance's Novo Nordisk position peaked at $1.52M in Q1 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.